摘要
目的探讨脾切除术（包括腹腔镜脾切除术）治疗某些血液病的手术指征、治疗效果及并发症的防治。方法对27例因血液系统疾病行脾切除的病历资料进行回顾性分析。结果遗传性球形红细胞增多症（HS，4例）：有效率100％；特发性血小板减少性紫癜（ITP，17例）：显效率76．47％（13／17）；非霍奇金淋巴瘤（NHL，6例）：切除脾脏有益于其综合治疗。术后并发症的发生率为7．41％（2／27）。结论脾切除治疗HS疗效肯定，是HS首选的治疗方法。脾切除治疗大多数ITP有效，应选择好适应证。ITP病人对皮质激素治疗的反应并不一定影响脾切除的疗效。对于恶性淋巴瘤，脾切除可作为其综合治疗措施中的主要手段。选择好手术适应证，做好围手术期处理，有益于减少并发症的发生。
Objective To explore the surgical indexes, therapeutic efficacy and prevention of complications in treatment of some blood diseases by splenectomy （including laparoscopic splenectomy）. Methods The clinical data of 27 patients with blood diseases receiving splenectomy in our bospi tal were retrospectively analyzed. Results The effective rate of splenectomy was 100% in 4 cases of hereditary spherocytosis, 76.47% in 17 cases of ITP and low in 6 cases of Non-Hodgkin＇s lymphoma. The postoperative incidence of complications was 7.41% （2/27）. Conelusion Splenectomy is of the first choice for treatment of hereditary spherocytosis. Meanwhile, it is effective for most of the patients with ITP. It is an important approach for comprehensive of malignant lymphoma. Proper choice of indications and perioperative management are helpful for decreasing incidence of postoperative complications.
出处
《中华肝胆外科杂志》
CAS
CSCD
北大核心
2009年第3期188-191,共4页
Chinese Journal of Hepatobiliary Surgery
